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Comparative sequence analyses, including such fundamental bioinformatics techniques as similarity searching, sequence
alignment and phylogenetic inference, have become a mainstay for researchers studying type 1 Human Immunodeficiency
Virus (HIV-1) genome structure and evolution. Implicit in comparative analyses is an underlying model of evolution, and the
chosen model can significantly affect the results. In general, evolutionary models describe the probabilities of replacing one
amino acid character with another over a period of time. Most widely used evolutionary models for protein sequences have
been derived from curated alignments of hundreds of proteins, usually based on mammalian genomes. It is unclear to what
extent these empirical models are generalizable to a very different organism, such as HIV-1–the most extensively sequenced
organism in existence. We developed a maximum likelihood model fitting procedure to a collection of HIV-1 alignments
sampled from different viral genes, and inferred two empirical substitution models, suitable for describing between-and
within-host evolution. Our procedure pools the information from multiple sequence alignments, and provided software
implementation can be run efficiently in parallel on a computer cluster. We describe how the inferred substitution models can
be used to generate scoring matrices suitable for alignment and similarity searches. Our models had a consistently superior fit
relative to the best existing models and to parameter-rich data-driven models when benchmarked on independent HIV-1
alignments, demonstrating evolutionary biases in amino-acid substitution that are unique to HIV, and that are not captured by
the existing models. The scoring matrices derived from the models showed a marked difference from common amino-acid
scoring matrices. The use of an appropriate evolutionary model recovered a known viral transmission history, whereas a poorly
chosen model introduced phylogenetic error. We argue that our model derivation procedure is immediately applicable to
other organisms with extensive sequence data available, such as Hepatitis C and Influenza A viruses.
Citation: Nickle DC, Heath L, Jensen MA, Gilbert PB, Mullins JI, et al (2007) HIV-Specific Probabilistic Models of Protein Evolution. PLoS ONE 2(6): e503.
doi:10.1371/journal.pone.0000503
INTRODUCTION
Nearly every computational and statistical method used for
comparative gene sequence analysis employ a stochastic model
for estimating rates of evolutionary change, either explicitly or
implicitly. A priori knowledge about physical or chemical properties
of nucleotide or amino acid residues can be used to define
mechanistic models of substitutions. For example, the popular
HKY85 [1] nucleotide substitution model estimates two separate
substitution rates: one for transitions-substitutions between chemi-
cally similar purines (adenine and cytosine) or pyrimidines
(guanine and thymine)-and one for transversions (all other
substitutions). Universal evolutionary constraints form another
basis for mechanistic model derivation. Codon models of Muse-
Gaut [2] and Goldman-Yang [3] distinguished amino-acid
altering (non-synonymous) and silent (synonymous) substitutions
and have formed the basis of a popular and successful suite of
methods for the analysis of selective pressures on coding
sequences.
Existing literature on probabilistic models for protein sequences
is extensive and spans several decades. One of the first of such
models was the PAM (point accepted mutation) matrix [4]. A
PAM matrix is derived from the inferred substitutions along
a phylogenetic tree relating homologous sequences, by estimating
the probability that any given amino acid residue in a protein will
be replaced by any other residue after a pre-specified evolutionary
interval. Other models based on observed sequence variability in
large alignments of homologous protein sequences, such as the
BLOSUM family [5], have proven popular and successful. Karlin
and Ghandour [6] and George, Barker, and Hunt [7] proposed
methods of weighting differences based on chemical, functional,
charge and structural properties of amino acids and computing
replacement probabilities based on the similarity of the involved
residues. Doolittle’s group proposed substitution matrices based on
amino acid structural similarities combined with the ease of
genetic interchange [8], while Stanfel added information pertain-
ing to biochemical properties to inform the probability of amino
acid interchangeability [9]. More recently, a generalized index of
exchangeability based on a meta-analysis of empirical data has
been suggested as a means of estimating the tolerability of
particular amino acid exchanges [10]. A similar method based on
pairwise amino-acid differences between homologous genes led to
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Index [11]. A more statistically robust method for model inference
incorporates phylogenetic likelihood [12], and infers substitution
rates from a seed alignment, e.g., from mitochondrial sequences
[13] or a sample from several protein families [14].
‘Generalist’ models that describe substitution patterns amal-
gamated from multiple genes and organisms may describe
a particular organism or gene poorly. To date, there have been
only a few ‘specialist’ models targeted to a particular gene [15], or
genomic region [13]. In this manuscript we lay out a maximum
likelihood framework and an accessible software implementation
for estimating an organism/gene specific evolutionary model and
alignment scoring matrix, describe common techniques for
validating the model and infer a model from a large collection
of HIV-1 sequences.
Reliable estimation of substitution rates from short sequences
(e.g. 10Kb viral genomes) requires a substantial degree of sequence
diversity, which may require millions of years to accumulate in
vertebrates or plants. However, rapidly evolving retroviruses, with
mutation rates of up to ,10
6 greater than that of vertebrates
[16,17], accumulate similar levels of divergence in a matter of
years and are abundantly represented in public databases. Dimmic
et al. [15] used a maximum likelihood procedure to estimate an
amino acid substitution rate matrix for specific application to
reverse transcriptase, a key retroviral polymerase protein that
transcribes viral RNA into DNA suitable for integration into the
host genome. However, we found that this model fitted HIV-1
data poorly, probably because HIV adopts organism-specific
substitution biases, different from other retroviruses.
To improve the predictive accuracy of substitution matrices for
HIV protein evolution, we estimated two stochastic models from
multiple representative HIV-1 sequence alignments using maxi-
mum likelihood. The first model was derived from HIV data
sampled from within individual patients (within individual, HIV
within, HIV-Wm). The second model was estimated from
alignments where every sequence represented a population
consensus from a patient (between individual, HIV between,
HIV-Bm). At first glance, one might question the need for two
separate models, since within-patient evolution could simply be
a shorter timescale version of the between-patient evolution. One
argument against this intuitive deduction is that most of the
substitutions generated in a given individual are selected against
during or following transmission and therefore do not persist at the
level of host populations [18–20], resulting in potentially
discordant substitution patterns. For example, substitutions which
enable the virus to escape the cellular immune response in a given
host can be rapidly generated and fixed [21]. However, many of
these substitutions carry a fitness cost in terms of lower replicative
capacity and are not likely to persist upon transmission to an
individual whose immune system does not target the same genetic
region of the virus, obviating the need for a fitness-lowering
substitution there [22]. Indeed, if there were no added benefit in
considering two models, one would see similar fits to both within
and between-host viral samples with both models. Our findings
strongly argue against this scenario (see ‘Results’), showing that
substitution patterns shaped by within-and between-host selective
regimes are detectably different.
METHODS
Preparation of reference sequence alignments
The HIV-Wm model was generated using aligned sequences
derived from 48 patients (encompassing portions of the env gene
from 32 patients, from the pro gene from 8, and from the pol gene
from 7 patients), which contained a total of 6,328 pairwise amino
acid differences. For the HIV-Bm model we used 8 data sets,
described in Table 1, with a total of 7,189 amino acid differences.
This number is far greater than the approximately 1,700
differences that were incorporated into the commonly used
Dayhoff PAM matrix and nearly twice the number in the
reference alignment used for the estimation of rtREV [15]
Estimation of the substitution model
We adopted a maximum likelihood phylogenetic approach based
on the procedure of Whelan and Goldman [14] to estimate the
190 evolutionary rates that define the general time reversible
(REV/GTR) model of amino-acid substitution jointly from a set of
sequence alignments. The substitution process is described by the
rate matrix Q, whose entry qij=rijpj (for i,j=1…20) defines the
instantaneous rate of replacing residue i with residue j, i.e. the
probability of substituting i with j over an infinitesimally small time
interval Dt is approximately qijDt. Residues are numbered based on
the alphabetical ordering of the standard IUPAC nomenclature.
pj(j=1…20) denotes the stationary frequency of residue j,
estimated by the proportion of j, and rij is the rate parameter.
Making the standard assumption of time reversibility, we set rij=rji.
In order to ensure that Q defines a proper Markov rate matrix, the
standard constraint is applied to the diagonal elements:
qii~{
X
j=i
qij.
The (i,j) entry of the matrix exponential T(t)=exp(Qt) defines
the probability of replacing residue i with residue j in time t$0.
Because the likelihood function depends only on the products qijt,
one of the 190 rate parameters rij is not identifiable. Following
convention, we achieve identifiably by scaling the rate matrix so
that the expected number of substitutions per amino-acid site per
unit time, defined as b~{
X
i
piqii, is one.
The fitting algorithm proceeds as follows:
1. Given N codon alignments, we first reconstructed a neighbor
joining tree [23] using the Tamura-Nei nucleotide distance
metric [24] separately for each alignment. We decided
against a more thorough method for topology reconstruction,
partly for computational expediency and partly because rate
estimation is thought to be fairly robust to small phylogenetic
Table 1. Data sets used for the estimation of the between-host
evolutionary process in HIV-1
......................................................................
Gene Sites
Sequences (One per
patient) Length
Mean branch Tree
gag 500 39 0.02 1.69
env gp120 463 107 0.047 9.87
env gp41 364 134 0.053 14.17
nef 202 117 0.034 7.88
pol 1003 43 0.018 1.52
rev exon 1 25 81 0.041 6.50
rev exon 2 90 171 0.032 11.01
tat 71 76 0.029 4.37
vpr 96 133 0.034 9.11
vpu 78 124 0.047 11.52
doi:10.1371/journal.pone.0000503.t001
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combination, and alignments with mosaic sequences cannot
be properly described with a single phylogeny. To address
this issue we carried out a screen for evidence of conflicting
phylogenetic signal [25] and did not find strong evidence for
phylogenetic discordance.
2. We estimated the equilibrium distribution of amino acid
residues jointly from the N alignments and held it constant
during the subsequent optimization procedure.
3. We used the HyPhy package [26] to perform a joint
numerical optimization of branch lengths for each of the N
alignments and the rates in the Q matrix. A flexible 5-bin
b2c distribution [27] of rates across sites was included to
account for the variation of substitution rates across sites.
The three parameters of the distribution were shared by all
N alignments. The numerical optimization algorithm in
HyPhy can distribute multiple-dataset optimization across
multiple nodes of a computer cluster, resulting in substantial
optimization time reductions.
4. Because some of the 190 possible substitutions are rare, it is
possible that the inference procedure estimates some of the rij
rates to be zero. However, fixing those estimates at zero for
subsequent analyses is not biologically realistic, since it
amounts to forcing some of the residue substitutions to
always go through an intermediate state. For each rate rij,
whose maximum likelihood estimate was zero, we imputed
the value of the rate using the following heuristic. If Si is the
total number of protein sites in alignment i and Ti is the
total length of its fitted phylogenetic tree, we set
rij~rji~
1
(pizzpj)
P
i~1
(1zSi)Ti
. This relation simply states
that we would expect one i«j substitution over all
alignments given one more site per alignment.
Performance on training data
We fitted newly estimated HIV models and three previously
published models-JTT [28], WAG [14] and rtREV [15],
estimating stationary frequencies from the data–to each of the
training alignments. A comparison of model fits via standard
techniques of likelihood ratio testing or AIC is complicated by the
fact that because HIV models are estimated from the same sample
that is being used to compare their fits to other models, it is
difficult to correctly enumerate the effective number of rate
parameters (and degrees of freedom) in HIV models when applied
to a single training set. For a given training set, this number lies
between 0 and 189 and depends on the contribution of the
individual set to the joint rate matrix. We tabulated log-likelihood
scores for each of the training data sets for reference purposes
(Tables S1 and S2) and computed the number of additional
degrees of freedom that an HIV model can support (at the 0.05
level) and still be preferred to each of the empirical models.
Model validation
To ensure that our substitution models reflect true evolutionary
patterns found in HIV-1 and are not fitting the noise in our
training sets, we collected a number of independent HIV-1
sequence samples that were not used in model development across
several genes, representing both within and between host
sequences. 47 within patient samples (35 envelope glycoprotein
(gp120) subtype B, 10 gp120 subtype C and 3 polymerase (pol)
subtype B) and 11 between patient samples (representing gag, pol,
nef, env, vif, vpr, tat and rev genes), covering both within- and
between-subtype levels of diversity were collected. We note that if
validation and training samples are not reciprocally monophyletic,
shared evolution along internal tree branches may bias validation
results. Within patient samples of HIV (assuming a single infection
event/patient) drawn from different hosts are reciprocally mono-
phyletic by definition, hence each alignment in the validation set
forms an independent sample. All of our between-patient
validation samples represent only non-B subtype non-recombinant
viruses, and hence are reciprocally monophyletic with the training
samples by definition of an HIV clade. We then fitted 19 models of
protein evolution, including HIV-specific models, to each sample
and ranked their performance using a small sample Akaike
Information Criterion (c-AIC) score [29]–a robust measure of
goodness of fit. We included six previously published empirical
matrices: Dayhoff [4], JTT [28], WAG [14], rtREV [15],
mtMAM [13] and mtREV 24 [30]. Each empirical model was
examined both with the original model character frequency
distribution (derived from the training set) and with frequencies
gathered from the test data (conventionally referred to as the+F
version of the model). We also fitted to each sample the 189
parameter reversible model (REV), and the restriction thereof
(REV-1 model), which estimates separate rates between those
amino-acids pairs that are one nucleotide substitution apart (75
pairs for the universal genetic code) and one shared rate for all
multiple-nucleotide substitutions.
Additionally, we applied the Shimodaira-Hasegawa test to
several example alignments to determine whether or not the
improvement in goodness-of-fit was influenced by sampling
variability. For example, it could be that most of the improvement
in c-AIC scores is derived from a few ‘outlier’ sites (scenario
sensitive to stochastic sampling) or that a majority of sites
contribute to the improvement in c-AIC (scenario robust to
stochastic sampling).
Generation of a similarity matrix
Similarity or scoring matrices, such as the BLOSUM [5] family,
assign to a pair of amino acids (a, b) a score that reflects how much
more (or less) likely a homologous pair (a, b) is to occur when
compared to a chance occurrence. The score can be estimated by
s(a,b)~log
f(ab)zf(ba)
2f(a)f(b)
, where f(a) is the frequency of residue
a in the reference set of aligned sequences, and f(ab) is the
frequency of the pair computed from pairwise comparisons of
homologous sequences in the reference set. The sum of all scores
over alignment columns for a query pair of sequences serves as an
approximation of the likelihood ratio statistic comparing the model
of independence (null) with the model of homology (alternative).
Given a frequency distribution of amino-acid characters p and
a transition matrix computed at time T(t0)=exp(Qt0), the score
s(a,b)~log
p(a)Tabzp(b)Tba
2p(a)p(b)
can be derived. The numerator
lists the probability of evolving ‘b’ from ‘a’ or ‘a’ from ‘b’ in time t0,
i.e., the probability of observing the (a,b) or (b,a) pair in two
homologous sequences evolving under Q, while the denominator
shows the probability of observing (a,b) or (b,a) in a pair of random
sequences with residues drawn from the distribution p. The choice
of t0 gives one control over how similar, on average, two sequences
will be, much like the selection of more or less similar reference
alignments gives rise to different BLOSUM and PAM matrices.
Setting t0~
c
{
P
i
piqii
will yield the expected sequence similarity
of (12c6100)%. Scores for aligning a character with a gap (‘-‘) can
be adjusted case by case, or adopted from an existing model, such
as BLOSUM62.
HIV Protein Model
PLoS ONE | www.plosone.org 3 June 2007 | Issue 6 | e503Implementation
All the analyses reported here were implemented in the HyPhy
software package. HyPhy scripts needed to fit a REV model to
a collection of training alignments and generate similarity scoring
matrices can be downloaded from http://www.hyphy.org/pubs/
HIV-model/. HIV-1 models presented here are available as a part
of the standard distribution of HyPhy (HIVWithin and HIVBetw-
een models). Protein model comparisons can be carried out using
the AAModelComparison.bf standard analysis in HyPhy. This
implementation can also take advantage of a distributed cluster
environment to accelerate rate estimation.
RESULTS
Characterization of inferred rate matrices
We first tabulated substitution rates inferred from the between-
patient training set (HIV-Bm model) and from the within-patient
training set (HIV-Wm model) and generated a graphical repre-
sentation of six popular empirical matrices along with our two
HIV specific matrices (Figure 1). Not surprisingly, most in-
stantaneous substitution rates are low when compared to the
highest rates in the matrix. Much like other empirical matrices, the
HIV models assigned higher rates to those pairs that are separated
by a single nucleotide substitution (see also Figure 2). However,
there was little apparent correlation between higher substitution
rates and preservation of a simple or complex physico-chemical
property. Preservation or alteration of polarity, charge or similarity
class, based on the classification scheme of Stanfel [9], had little
effect on the median substitution rate (Figure 2), although among
those few substitutions which had unusually high rates, more were
conservative.
Model-specific variability along with broad patterns of similarity
are evident among all of the empirical models in Figure 1. To
formally characterize the similarities in the substitution process
across the eight matrices, we computed a neighbor-joining tree on
the Markov processes defined by each matrix using the total
variation metric (TVM) [31]. Briefly, given a specific evolutionary
time scale, TVM computes the distance between the expected
distributions of characters generated under the two evolutionary
models. TVM distances take values in [0,1]. As expected, HIV-
Bm and HIV-Wm models are most similar to each other over
short (0.05 expected substitutions per site), medium (0.25) and long
(1.0) evolutionary scales (Figure 3). In particular, HIV matrices
define substitution patterns that are distinct from all other
empirical models at several evolutionary time-scales. Somewhat
surprisingly, the next closest set of matrices is that derived from
mitochondrial sequences, except for the long evolutionary scale,
when the rtREV model (derived from a viral reverse transcriptase
protein alignment) becomes most similar to the HIV models.
While counterintuitive, this finding seems less unexpected when
one considers how the training sets were chosen for each of the
models. Indeed, the Dayhoff, JTT, WAG and rtREV models were
all trained on sequences that are much more heterogeneous,
gearing them towards long-range evolutionary homologies.
Model validation using independent data sets
To determine whether HIV Within and HIV Between models
reflect evolutionary patterns found in circulating HIV-1 strains,
rather than simply fitting the noise in the training sample, we
tested model fits on samples of HIV-1 sequences not included in
the training set. The results on samples collected from 47 different
patients (the sequences from each patient formed a distinct test
Figure 1. Rate matrices for different substitution models. All matrices are scaled to one expected substitution per unit time per site. Shading of the
cells reflects the respective magnitude of the rate, with darker shades corresponding to increasingly higher rates. Substitutions which involve a single
nucleotide are marked with a circle. The four diagonal blocks represent similarity classes (conservative substitutions) according to the Stanfel scale.
doi:10.1371/journal.pone.0000503.g001
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(range 330–473), representing env and pol sequences from subtype
B and subtype C viruses are shown in Tables 2 and 3. In 44/47
cases, the HIV-Wm model with base frequencies estimated from
the sample had the best small sample Akaike Information
Criterion score (c-AIC) score of all 19 models compared. The c-
AIC score of a model is defined as c-AIC=2(2L+ps/(s2p21)),
where L is the log-likelihood score of the model, p is the number of
estimated model parameters, and s is the number of independent
samples. There are a number of possible ways to estimate the
number of independent samples in the alignment [32] and we
chose to use the number of alignment columns as an estimate of s.
c-AIC performed well in selecting appropriate evolutionary
models on biological and simulated alignments of paired RNA
sequences [33]. In 2/47 cases, the HIV-Wm model with the
frequencies from the training set was the best and in 1/47 cases,
the HIV-Bm model was the best. In fact, the four HIV models
predominantly occupied the four top ranks, suggesting that no
other empirical model adequately represents the evolutionary rates
shaping HIV-1 genomic variation. The REV-1 and JTT (+F)
models were 5
th and 6
th, respectively. Surprisingly, three models
based on large heterogeneous database samples (JTT, WAG and
mtMAM) outperformed the rtREV model, which was derived
from a viral training dataset. Perhaps more importantly, our
general HIV model estimated across many of the HIV genes
consistently outperformed the rtREV model on sequence samples,
including the HIV-1 reverse transcriptase protein.
The difference in c-AIC scores between two models can be
interpreted as strength of evidence in favor of the model with the
lower score. For instance, the evidence ratio for models A and B,
R(A,B) is defined as R(A,B)=exp[(AICC(B)2AICC(A))/2], and can
be interpreted as the relative probabilities of the two models
Figure 2. Inferred substitution rates. Rates are classified by whether or not a substitution involves single or multiple nucleotide changes, and by how
they affect various properties of the residue being substituted. HIV-Bm model is plotted in the top row and HIV-Wm model-in the bottom row.
doi:10.1371/journal.pone.0000503.g002
Figure 3. Model clustering using the Total Variation Metric at the evolutionary times equivalent to 5%, 25% and 100% sequence divergences.
doi:10.1371/journal.pone.0000503.g003
HIV Protein Model
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difference in c-AIC between HIV-Wm and the best-fitting
previously described empirical model was sufficiently large
(median 125 points, range 13.3–259.5) to render the latter model
not credible, with R(HIV-Wm,best existing empirical model) .50
for every tested dataset. Furthermore, in 46/47 cases when HIV-
Wm(+F) outperformed HIV-Bm(+F), R(HIV-Wm, HIV-Bm) was
at most 0.011 (c-AIC difference range 9.0–215.3, median 94.4),
confirming that a within-patient model for HIV is sufficiently
different from the between-host model, supporting our argument
for the need to derive these two distinct models. Table 3 provides
a pairwise comparison of model performance by listing the
number of times model A had evidence ratio in excess of 100 when
compared to model B. For instance, HIV-Wm had very strong
evidence ratio support against all competing models in the vast
majority of cases.
The results for 11 between-patient samples (where each sample
contained a single sequence from each host), with a median of 37
sequences (range 22–119) and 442 sites (range 79–953) are shown
in Tables 4 and 5. In 7/11 cases HIV-Bm was the best fitting
model (in all 11 cases it scored in the top 3), REV-1 was best in 4/
11 cases. JTT consistently scored best among the existing
empirical models, but always fit worse than HIV-Bm (e.g., when
it came in second, HIV-Bm was first, see Table 5). In all 11 cases
the difference in c-AIC between HIV-Bm and the best-fitting
previously described empirical model was sufficiently large
(median 38.42 points, range 6.5–345.5) to suggest that previous
empirical models fitted the data poorly, with R(HIV-Bm,best
existing empirical model) .25 for every tested dataset. In addition,
HIV-Bm, consistently outperformed HIV-Wm, corroborating our
original supposition for the need for two distinct models. The
finding that the estimation of 76 rate parameters from the data was
worthwhile in 4/11 cases is not surprising in retrospect. Some of
the datasets we evaluated comprised multiple HIV subtypes with
more variation and divergence than had been included in our
subtype B-only training data. In fact, all 4 cases where REV-1 was
found to be best, the sequences came from the Los Alamos
National Laboratory HIV database subtype reference alignment
spanning all common HIV-1 (clade M) subtypes. Furthermore,
HIV-Bm consistently outperformed all other empirical models.
Sensitivity to stochastic sampling
We focus on a sample data set to investigate whether or not the
improvement in model fit attained by HIV-specific models is
driven by a few strong improvements at ‘outlier’ sites, or by
consistent but smaller improvements at many sites in an
alignment. A formal way to quantify the effect of stochastic
sampling is to perform a Shimodaira-Hasegawa permutation test
on columns of an alignment, compute the difference in log-
likelihood scores of two competing models on each replicate (if
they have the same number of parameters), and test the hypothesis
that the difference is different from zero. We illustrate this on
a sample of 119 pol sequences each sampled from a different host
infected with subtype C HIV-1, with 951 sites each. The likelihood
scores for three models on this alignment are as follows: HIV-Bm
log L=221653.1, JTT log L=221825.9, rtREV
logL=222383.4. Because the models have the same number of
parameters, a better log likelihood leads to a better c-AIC score.
When comparing HIV-Bm to rtREV, we found that HIV-Bm had
higher likelihoods at 580/951 (61%) sites, with the median
improvement of 0.99 (range of 0.002 to 37.9) log-likelihood points
per site, whereas at the sites where rtREV performed better, the
median difference was 0.7 (range 0–31.6). Based on 10,000
permutations, the SH test returned a p-value of ,0.0001 in favor
of HIV-Bm having a better fit. In a comparison HIV-Bm to JTT,
the p-value in favor of HIV-Bm was ,0.018, HIV-Bm fitted
better on 557/951 (58.6%) sites, with the median improvement of
0.54 (0.0009–23.67) on those sites, and of 0.53 (0.00001–22.75) on
those where JTT performed better. The largest improvement in
favor of HIV-Bm occurred at sites where there was significant
polymorphism with 2 or 3 amino-acids estimated to have high
substitution rates in HIV-1. For example, site 311 with base
composition K75R41Q2G1 yielded improvements of over 20 log-
likelihood points with HIV Between, when compared to JTT or
rtREV. Note that HIV-Bm assigned higher rates to K«R than
either JTT or rtREV, accommodating such variability (Figure 1).
Effect of model misspecification on phylogenetic
reconstruction
We consider seven HIV-1 env V3 loop sequences sampled from an
epidemiological cluster with known transmission history and hence
a known phylogenetic tree, used as a study case by [35]. With
seven sequences it is easy to perform an exhaustive search of all
945 unrooted trees and eliminate the influence of search heuristics.
Thus any differences observed would be driven by model
specification. The correct topology for the seven sequences is
inferred by the HIV-Bm model, but not by the Dayhoff model
(Figure 4) for example. We note that better-fitting empirical
models (e.g. JTT or WAG) recover the correct topology, and we
use this example merely to illustrate that a poor or unjustified
model choice may lead to erroneous results.
Effect of model on evolutionary distance estimation
Model-based estimation of sequence divergence and diversity from
sequence samples is a ubiquitous technique in HIV literature [36].
To examine the effect that an evolutionary model can have on the
Table 2. Relative performance of 19 protein models on
a sample of 47 within-patient HIV-1 alignments
1
......................................................................
Rank/Model 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
HIV-Wm 4 4 201000000000000000
HIV-Wm+F 24 3 20000000000000000
HIV-Bm 101 8 1 6 632100000000000
HIV-Bm+F 012 0 1 8 511010000000000
REV-1 step 0 1 3 0 2 2 3 3 5 4 171136140
JTT+F 00472 2 1 2 2000000000000
J T T 000592 1 1 0 110000000000
WAG+F 0000172 2 1 4 21000000000
mtMAM+F 000010121126141 4 1 3 100
r t R E V 00001011000292 2 1 0 1000
mtREV 24+F 0000010664871 1 400000
W A G 00000051 3 1 8 5312000000
Dayhoff+F 000000061 0 2 3 610100000
rtREV+F 00000000241 4 1 4 1 2 100000
D a y h o f f 00000000151 2 91 0 1 0 00000
Equal Input 0 0 0 0 0 0 0 0 0 0 10141 9 1 7 410
m t R E V 2 4 00000000000000173 7 20
m t M A M 000000000000000233 9 3
R E V 0000000000000001114 4
1Based on small sample Akaike Information Criterion
doi:10.1371/journal.pone.0000503.t002
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
HIV Protein Model
PLoS ONE | www.plosone.org 6 June 2007 | Issue 6 | e503T
a
b
l
e
3
.
T
h
e
n
u
m
b
e
r
o
f
t
i
m
e
s
a
m
o
d
e
l
h
a
d
e
v
i
d
e
n
c
e
r
a
t
i
o
o
f
1
0
0
o
r
b
e
t
t
e
r
a
g
a
i
n
s
t
e
v
e
r
y
c
o
m
p
e
t
i
n
g
m
o
d
e
l
o
n
t
h
e
4
7
w
i
t
h
i
n
-
p
a
t
i
e
n
t
v
a
l
i
d
a
t
i
o
n
d
a
t
a
s
e
t
s
.
1
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
H
I
V
-
W
m
H
I
V
-
W
m
+
F
H
I
V
-
B
m
H
I
V
-
B
m
+
F
R
E
V
-
1
s
t
e
p
J
T
T
+
F
J
T
T
W
A
G
+
F
M
t
M
A
M
+
F
r
t
R
E
V
m
t
R
E
V
2
4
+
F
W
A
G
D
a
y
h
o
f
f
+
F
r
t
R
E
V
+
F
D
a
y
h
o
f
f
E
q
u
a
l
I
n
p
u
t
m
t
R
E
V
2
4
m
t
M
A
M
R
E
V
H
I
V
-
W
m
0
4
5
4
4
4
6
4
7
4
6
4
7
4
7
4
7
4
6
4
7
4
7
4
7
4
7
4
7
4
7
4
7
4
7
4
7
H
I
V
-
W
m
+
F
1
0
4
5
4
6
4
6
4
6
4
6
4
7
4
7
4
7
4
7
4
7
4
7
4
7
4
7
4
7
4
7
4
7
4
7
H
I
V
-
B
m
0
1
0
1
5
4
3
3
0
3
9
4
3
4
6
4
6
4
6
4
6
4
6
4
7
4
7
4
7
4
7
4
7
4
7
H
I
V
-
B
m
+
F
0
0
1
5
0
4
3
3
7
4
0
4
4
4
7
4
6
4
7
4
6
4
7
4
7
4
7
4
7
4
7
4
7
4
7
R
E
V
-
1
s
t
e
p
0
1
4
4
0
6
6
1
1
3
1
3
2
2
2
1
4
1
7
2
4
2
8
3
5
4
1
4
3
4
7
J
T
T
+
F
0
0
8
5
4
0
0
2
8
4
7
4
6
4
6
4
7
4
7
4
7
4
7
4
7
4
7
4
7
4
7
4
7
J
T
T
0
0
3
3
3
8
4
0
3
5
4
4
4
6
4
5
4
7
4
7
4
6
4
7
4
7
4
7
4
7
4
7
W
A
G
+
F
0
0
3
1
3
4
0
5
0
4
3
4
4
4
3
3
9
4
2
4
6
4
7
4
7
4
7
4
7
4
7
M
t
M
A
M
+
F
0
0
0
0
1
6
0
0
2
0
1
4
2
6
4
7
1
2
3
1
4
7
4
7
4
6
r
t
R
E
V
0
0
0
0
1
2
0
1
2
2
9
0
8
1
3
3
4
3
9
4
7
4
7
4
7
M
t
R
E
V
2
4
+
F
0
0
0
0
1
8
0
1
1
4
1
3
7
0
7
7
2
2
2
5
4
7
4
7
4
7
4
7
W
A
G
0
0
0
1
2
9
0
0
2
4
0
4
5
3
5
0
3
0
3
9
4
3
4
6
4
7
4
7
4
7
D
a
y
h
o
f
f
+
F
0
0
0
0
2
6
0
0
0
3
9
4
3
2
9
8
0
3
6
4
3
4
6
4
7
4
7
4
7
r
t
R
E
V
+
F
0
0
0
0
1
9
0
0
0
3
5
4
1
2
0
2
1
0
2
0
4
6
4
7
4
7
4
7
D
a
y
h
o
f
f
0
0
0
0
1
8
0
0
0
3
2
3
9
1
7
0
1
1
7
0
4
4
4
7
4
7
4
7
E
q
u
a
l
I
n
p
u
t
0
0
0
0
1
1
0
0
0
1
4
2
0
1
0
1
2
0
4
1
4
6
4
7
m
t
R
E
V
2
4
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
4
0
4
3
4
5
m
t
M
A
M
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
1
0
4
4
R
E
V
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
3
0
1
M
o
d
e
l
s
a
r
e
a
r
r
a
n
g
e
d
b
y
d
e
c
r
e
a
s
i
n
g
r
a
n
k
p
e
r
f
o
r
m
a
n
c
e
(
s
e
e
T
a
b
l
e
2
)
d
o
i
:
1
0
.
1
3
7
1
/
j
o
u
r
n
a
l
.
p
o
n
e
.
0
0
0
0
5
0
3
.
t
0
0
3
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
HIV Protein Model
PLoS ONE | www.plosone.org 7 June 2007 | Issue 6 | e503estimates of evolutionary distances between protein sequences we
fitted four empirical models to 11 between-patient HIV alignments
(Table S3). While median pairwise estimates (i.e. the total tree
length) was not dramatically affected by the model choice (up to
5% relative error), for a particular pair of sequences, the estimates
could vary by as much as 630%.
HIV similarity matrices
We compared our scoring matrices with the typically used
BLOSUM62 scoring matrix with ours scaled to the same level of
divergence (62% expected sequence identity). HIV matrices penalize
(by assigning large magnitude negative scores) most kinds of
substitutions more heavily than the BLOSUM62, perhaps represent-
ing the fact that long stretches of HIV-1 genomes are quite conserved
(e.g. integrase). Figure 5 demonstrates the point. The BLOSUM62
matrix is relatively flat with many non-identities penalized relatively
lightly and diagonal elements (identities) rewarded moderately. HIV
matrices reward identities with higher scores than BLOSUM62 and
tend to heavily penalize most non-identities.
DISCUSSION
We constructed two empirical HIV-1 subtype B amino acid
substitution models to better describe patterns of HIV evolution,
one based on among-patient sequences (HIV-Bm), and the other
based on within-patient sequences (HIV-Wm). Our implementa-
tion is straightforward and relies on well-regarded methods of
maximum likelihood phylogenetic inference. Indeed, a researcher
can build an empirical amino acid model for any taxon or clade of
choice assuming there is sufficient sequence data to estimate most
of the rates reliably. In a direct comparison between the two HIV
models, we find them to be similar, yet in our cross validation
study we find that the HIV-Wm fits significantly better to within-
patient data than the HIV-Bm models and vice versa. But most
importantly, our HIV specific models fit dramatically better than
any commonly used amino acid models, and nearly always better
than parameter rich reversible models which estimate rates
directly from the data set being tested. This finding suggests that
empirical HIV models are generalizable to independent samples of
HIV and can be recommended as the default matrices for
comparative HIV analyses. Interestingly, the JTT model provided
the best fit to our samples of HIV data among existing empirical
models, which is in direct conflict with the observations made by
Dimmic et al. [15].
A possible component of poor fit shown by existing empirical
matrices on HIV sequences is the assumption that the sequences
being compared have the same average amino acid composition as
that used in producing the model. Because HIV sequences almost
certainly do not have the same amino acid frequencies as those
built into prior empirical matrices, the inclusion of HIV specific
residue frequencies can be expected to improve the models.
However, this is not the sole determinant of better model fits,
because allowing for HIV-specific residue composition in existing
empirical models (+F) failed to match the improvement in fit
garnered by the use of HIV-specific substitution rates.
The lack of strong correlation between substitution rate and
simple amino acid properties may be explained by the fact that
because these models average rates over sites in different genes,
which are subject to varying functional constraints, no single
property can be expected to explain tremendous local variation
well. This is true of other empirical models as well, as evidenced by
the large number of shaded (high rate) pairs outside diagonal
boxes, which reflect radical substitutions according to the Stanfel
scale (Figure 1).
HIV specific models will improve the accuracy in measurements
of evolutionary distance and phylogenetic inference on HIV
sequences. For example, our models identify the correct phylogeny
in a known transmission chain [35], whereas a poorly chosen
model does not. The HIV-specific protein models of evolution
could be used to tailor drug therapies against strains of viruses that
maximize the protein distance that the virus would have to evolve
to develop drug resistance. The use of more accurate evolutionary
models can be used to improve the design of candidate vaccine
strains, particularly those based on computationally derived
sequences (e.g. Center-Of-Tree (COT) [37]). The models also
have applications for comparing amino acid frequencies and
patterns between sequence sets, and for generating HIV-like
sequencedata sets incomputersimulation studies.Inthismanuscript
we focused on organism-wide substitution patterns and our
validation process convincingly showed that HIV models out-
performed existing empirical models on a variety of individual gene
alignments. Further possible refinements could include gene specific
matrices for commonly sequenced viral genes such as pol or env.
The HIV-specific scoring matrices provided here should
improve HIV sequence similarity searching (e.g. BLAST) and
alignment (e.g. CLUSTALW). All sequence analyses that produce
an alignment use a scoring matrix (e.g. BLOSUM) to weight the
probability of an observed substitution. Sometimes these matrices
are uninformative and treat all substitutions equally likely, but
nearly all protein sequence based procedures use a matrix that
ranks certain types of substitutions as more tolerable than others.
We developed an efficient computational tool to facilitate the
estimation of substitution matrices from training alignments and
subsequent generation of scoring matrices at the desired level of
evolutionary distance. We believe that with readily accessible
modern computing power, it is now feasible to estimate and use
organism specific empirical matrices for protein sequence analysis
Table 4. Relative performance of 19 protein models on
a sample of 11 between-patient HIV-1 alignments
1
......................................................................
Rank/Model 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
HIV-Bm 7211000000000000000
REV-1 step 4 0 0 1 2 0 0 0 0 0 000000103
HIV-Wm 0521110100000000000
J T T 0233001011000000000
HIV-Bm+F 0200010001000010132
R E V 0031103110010000000
JTT+F 0011411111000000000
W A G 0010200010032110000
D a y h o f f 0003002320100000000
HIV-Wm+F 0000131201210000000
m t M A M 0000040104110000000
r t R E V 0000011032201100000
WAG+F 0000002000000113400
m t R E V 2 4 0000000200000001161
mtREV 24+F 0000000010442000000
Dayhoff+F 0000000010114220000
rtREV+F 0000000001002530000
mtMAM+F 0000000000000136100
Equal Input 0 0 0 0 0 0 0 0 0 0 000001325
1Based on small sample Akaike Information Criterion
doi:10.1371/journal.pone.0000503.t004
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PLoS ONE | www.plosone.org 9 June 2007 | Issue 6 | e503using powerful statistical techniques. Increased accuracy in compar-
ative analyses, in our minds, is well worth the additional effort.
SUPPORTING INFORMATION
Table S1 Relative performance of HIV-B
m and three empirical
models on between-host training data. Relative D.F. shows the
number of additional degrees of freedom that HIV-B
m can have
and still be preferred (by nested LRT at p=0.05) to a given
empirical model (see text).
Found at: doi:10.1371/journal.pone.0000503.s001 (0.03 MB
DOC)
Table S2 Relative performance of HIV-W
m and three empirical
models on between-host training data. Relative D.F. shows the
number of additional degrees of freedom that HIV-W
m can have
and still be preferred (by nested LRT at p=0.05) to a given
empirical model (see text).
Found at: doi:10.1371/journal.pone.0000503.s002 (0.10 MB
DOC)
Table S3 The effect of evolutionary model on pairwise distance
estimates using 11 between patient datasets. HIV-B
m is used as
a reference model to compute tree-based pairwise distances, and
relative differences for 3 existing empirical models are shown for
each dataset.
Found at: doi:10.1371/journal.pone.0000503.s003 (0.04 MB
DOC)
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